Immune-associated cells in basal cell carcinomas of skin

Journal of Cutaneous Pathology

Volumn 23, Issue 2, 1996, Pages 140-146

  Deng, J S ^a,b   Brod, B A ^a   Saito, R ^a,b   Tharp, M D ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AVIDIN; FLUORESCEIN ISOTHIOCYANATE; MONOCLONAL ANTIBODY;

ARTICLE; B LYMPHOCYTE; BASAL CELL CARCINOMA; CELL POPULATION; CLINICAL ARTICLE; HELPER CELL; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LANGERHANS CELL; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; MAST CELL; NATURAL KILLER CELL; T LYMPHOCYTE; TISSUE SECTION;

CARCINOMA, BASAL CELL; HUMANS; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; LYMPHOCYTES, TUMOR-INFILTRATING; MAST CELLS; SKIN NEOPLASMS; T-LYMPHOCYTES;

EID: 0029933160     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1996.tb01287.x     Document Type: Article

References (46)

1. Pollack SV, Goslen JB, Sherertz EF. The biology of basal cell carcinoma: A review. J Am Acad Dermatol 1982: 7: 569.
2. Christensen M, Briggs RM, Coblentz MG, Shapiro MJ, Rickert RR. Metastatic basal cell carcinoma: A review of the literature and report of two cases. Am Surg 1978: 44: 382.
3. Dellon AL, Potvin C, Chretien PB, Rogentine CN. The immunobiology of skin cancer. Plastic and Reconstructive Surgery 1975: 55: 341.
4. Bustamante R, Schmitt D, Pillet C, Thivolet J. Immunoglobulin producing cells in the inflammatory infiltrates of cutaneous tumors. Immunocytologic identification in situ. J Invest Dermatol 1977: 68: 346.
5. Viac J, Bustanente R, Thivolet J. Characterization of mononuclear cells in the inflammatory infiltrates of cutaneous tumors. Br J Dermatol 1977: 97: 1.
6. de Panfilis G, Colli V, Manfredi G, et al. In situ identification of mononuclear cells infiltrating cutaneous carcinoma: An immunohistochemical study. Acta Derm Venereol (Stockh) 1979: 59: 219.
7. Eaglstein NF, Hernandez AD, Allen JE. Lymphocytic response to basal cell carcinoma in situ identification of functional subsets using monoclonal antibodies. J Dermatol Surg Oncol 1982: 8: 943.
8. Synkowski DR, Schuster P, Orlando JC. The immunobiology of basal cell carcinoma: An in situ monoclonal antibody study. Br J Dermatol 1985: 113: 441.
9. Werner-Habets JM, Tank B, Vuzevski VD, Van Reede EC, Stolz E, van Joost T. Characterization of the mononuclear infiltrate in basal cell carcinoma: A predominantly T cell mediated immune response with minor participation of leu-7+ (natural killer) cells and Leu-14+ (B) cells. J Invest Dermatol 1988: 90: 289.
10. Smolle J, Soyer HP, Ehall R, Bartenstein S, Kerl H. Langerhans cell density in epithelial skin tumors correlate with epithelial differentiation but not with the peritumoral infiltrate. J Invest Dermatol 1986: 87: 477.
11. Hunt MJ, Halliday GM, Weedon D, Cooke BE, Barnetson R St. C. Regression in basal cell carcinoma: an immunohistochemical analysis. Br J Dermatol 1994: 130: 1.
12. Cawley EP, Hoch-Ligeti C. Association of tissue mast cells and skin tumors. Arch Dermatol 1961: 83: 146.
13. Roche WR. Mast cells and tumors. The specific enhancement of tumor proliferation in vitro. Am J Pathol 1985: 119: 57.
14. Csaba G, Acs T, Horvath C, Mold K. Genesis and function of mast cells: mast cell and plasmocyte reaction to induced homologous and heterologous tumors. Br J Cancer 1961: 15: 327.
15. Henderson WR, Chi EY, Jong EC, Klebanoff SJ. Mast cell-mediated tumor-cell cytotoxicity. J Exp Med 1981: 153: 520.
16. Bergstresser PR, Tiegelaar RE, Tharp MD. Conjugated avidin identifies cutaneous rodent and human mast cells. J Invest Dermatol 1984: 83: 214.
17. Walls AF, Jones DB, WilliamsJH, Church MK, Holgate ST. Immunohistochemical identification of mast cells in formaldehyde-fixed tissue using monoclonal antibodies specific for tryptase. J Pathol 1990: 162: 119.
18. Hsu SM, Raine L, Fanger H. A comparative study of the peroxidase-anti-peroxidase method and an avidin-biotin complex method for studying polypeptide-hormones with radioimmunoassay methods. Am J Clin Pathol 1981: 75: 734.
19. Habets JM, Tank B, Vuzevski VD, et al. An absence of human leucocyte antigen-DR and a decreased expression of beta-2-micro globulin on tumor cells of basal cell carcinoma. No influence on the peritumoral immune infiltrates. J Am Acad Dermatol 1989: 20: 47.
20. Hua LA, Kagen CN, Carpenter RJ, et al. HLA and beta-2-microglobulin expression in basal and squamous cell carcinomas of the skin. Int J Dermatol 1985: 24: 660.
21. Natali PG, Viora M, Nicotra MR, et al. Antigenic heterogeneity of skin tumors of nonmelanocyte origin: analysis with monoclonal antibodies to tumor-associated antigens and to histocompatibility antigens. J Natl Cancer Inst 1983: 71: 439.
22. Guillen FJ, Day CL Jr, Murphy GF. Expression of activation antigens by T cell infiltrating basal cell carcinomas. J Invest Dermatol 1985: 85: 203.
23. Hersey P, MacDonald M, Schibeci S, Burns C. Clonal analysis of cytotoxic T lymphocytes (CTL) against autologous melanoma. Cancer Immunol Immunother 1986: 22: 15.
24. Topalian SL, Solomon D, Rosenberg SA. Tumor specific cytolysis by lymphocytes infiltrating human melanomas. J Immunol 1989: 142: 3714.
25. Greenberg PD. Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor sells. Adv Immunol 1991: 49: 281.
26. Griffiths GM. Expression of perform and granzymes in vivo: potential diagnostic markers for activated cytotoxic cells. Immunol today 1991: 12: 415.
27. Griffiths GM, Alpert S, Lamberg E, Mcguire J, Weissman IL. Perform and granzyme A expression indentifying cytolytic lymphocytes in rheumatoid arthritis. Proc Natl Acad Sci USA 1992: 89: 549.
28. Henderson WR, Chi EY, Jong EC, Klebanoff SJ. Mast cell-mediated tumor-cell cytotoxicity. Role of the peroxidase system. J Exp Med 1981: 153: 520.
29. Young JD, Liu CC, Butler G, Cohen ZA, Galli SJ. Identification, purification and characterization of a mast cell-associated cytolytic factor related to tumor necrosis factor. Proc Natl Acad Sci USA 1987: 84: 9175.
30. Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF. Human dermal mast cells contain and release tumor necrosis factor-alpha, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci USA 1991: 88: 4220.
31. Gordon JR, Burd PR, Galli SJ. Mast cells as a source of multifunctional cytokines. Immunology Today 1990: 11: 458.
32. Scheurich P, Thomas B, Ucer U, et al. Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: Induction of TNF receptors on human T cells and TNF-alpha mediated enhancement of T cell responses. J Immunol 1987: 138: 1786.
33. Yokota S, Geppert TD, Lipsky PE. Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-alpha. J Immunol 1988: 140: 531.
34. Tharp M, Schechter N, Lazarus G, Chan IJ. Mast cell-derived chymase mediates tumor cytotoxicity. J Invest Dermatol 1991: 96: 551. (Abstract).
35. Guy-Grand D, Dy M, Luffau G, Vassalli P. Gut mucosal mast cells: Origin, traffic and differentiation. J Exp Med 1984: 160: 12.
36. Ruitenberg EJ, Elgersma A. Absence of intestinal mast cell response in congenitally athymic mice during Trichinella spiralis infection. Nature (London) 1976: 264: 258.
37. Yokota T, Lee F, Rennick D, et al. Isolation and characterization of a mouse cDNA clone that expresses mast cell growth factor activity in monkey cells. Proc Natl Acad Sci USA 1984: 81: 1070.
38. Fung MC, Hapel AJ, Ymer S, et al. Molecular cloning of cDNA for murine interleukin-2. Nature (London) 1984: 307: 233.
39. Hamaguchi Y, Kanakura Y, Fujita J, et al. Interleukin-4 as an essential factor for in vitro clonal growth of murine connective tissue-type mast cells. J Exp Med 1987: 165: 268.
40. Ihle JN, Keller J, Oeroszlan S, et al. Biological properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth-factor activity, mast cell growth-factor activity, P cell-stimulating activity, colony-stimulating factor activity and histamine-producing cell-stimulating factor activity. J Immunol 1983: 131: 282.
41. Dvorak AM, Mihm MC Jr., Dvorak HF. Morphology of delayed-type hypersensitivity reactions in man. II. Ultrastructural alterations affecting the microvasculature and the tissue mast cells. Lab Invest 1976: 34: 179.
42. Askenase PW. Mechanisms of hypersensitivity: Cellular interactions. J Allergy 1979: 64: 79.
43. Rocklin RE, Breard J, Gupta S, Good RA, Melmon KL. Characterization of the human blood lymphocytes that produce a histamine induced suppressor factor (HSF). Cell Immunol 1980: 51: 226.
44. Rocklin RE, Haberek-Davidson A. Histamine activates suppressor cells in vitro using a coculture technique. J Clin Immunol 1981: 1: 73.
45. Mitsui H, Furitsu T, Dvorak AN, et al. Development of human mast cells from umbilical cord blood cells by recombinant human and murine c kit ligand. Proc Natl Acad Sci USA 1993: 90: 735.
46. Rau K, Demitsu T, Puglielli E, Tharp MD. Effect of human recombinant stem cell factor on human cutaneous mast cells. J Invest Dermatol 1995: 104: 677. (Abstract).